These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2476109)

  • 101. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression.
    Hastie KM; Kimberlin CR; Zandonatti MA; MacRae IJ; Saphire EO
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2396-401. PubMed ID: 21262835
    [TBL] [Abstract][Full Text] [Related]  

  • 102. In silico prediction of B- and T- cell epitope on Lassa virus proteins for peptide based subunit vaccine design.
    Verma SK; Yadav S; Kumar A
    Adv Biomed Res; 2015; 4():201. PubMed ID: 26601089
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Immunological cross-reactions and interactions between the Drosophila melanogaster ref(2)P protein and sigma rhabdovirus proteins.
    Wyers F; Dru P; Simonet B; Contamine D
    J Virol; 1993 Jun; 67(6):3208-16. PubMed ID: 7684462
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Establishment of Recombinant Trisegmented Mopeia Virus Expressing Two Reporter Genes for Screening of Mammarenavirus Inhibitors.
    Oestereich L; Wurr S; Becker-Ziaja B; Bockholt S; Pahlmann M; Cadar D; Kümmerer BM; Günther S; Kerber R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146676
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Validation of Inactivation Methods for Arenaviruses.
    Olschewski S; Thielebein A; Hoffmann C; Blake O; Müller J; Bockholt S; Pallasch E; Hinzmann J; Wurr S; Neddersen N; Rieger T; Günther S; Oestereich L
    Viruses; 2021 May; 13(6):. PubMed ID: 34073735
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Experimental Morogoro Virus Infection in Its Natural Host,
    Hoffmann C; Wurr S; Pallasch E; Bockholt S; Rieger T; Günther S; Oestereich L
    Viruses; 2021 May; 13(5):. PubMed ID: 34067011
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.
    Bonilla WV; Kirchhammer N; Marx AF; Kallert SM; Krzyzaniak MA; Lu M; Darbre S; Schmidt S; Raguz J; Berka U; Vincenti I; Pauzuolis M; Kerber R; Hoepner S; Günther S; Magnus C; Merkler D; Orlinger KK; Zippelius A; Pinschewer DD
    Cell Rep Med; 2021 Mar; 2(3):100209. PubMed ID: 33763654
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea.
    Mariën J; Lo Iacono G; Rieger T; Magassouba N; Günther S; Fichet-Calvet E
    Emerg Microbes Infect; 2020 Dec; 9(1):1055-1064. PubMed ID: 32459576
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Vaccine platforms for the prevention of Lassa fever.
    Purushotham J; Lambe T; Gilbert SC
    Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
    Hallam HJ; Hallam S; Rodriguez SE; Barrett ADT; Beasley DWC; Chua A; Ksiazek TG; Milligan GN; Sathiyamoorthy V; Reece LM
    NPJ Vaccines; 2018; 3():11. PubMed ID: 29581897
    [TBL] [Abstract][Full Text] [Related]  

  • 111. No measurable adverse effects of Lassa, Morogoro and Gairo arenaviruses on their rodent reservoir host in natural conditions.
    Mariën J; Borremans B; Gryseels S; Soropogui B; De Bruyn L; Bongo GN; Becker-Ziaja B; de Bellocq JG; Günther S; Magassouba N; Leirs H; Fichet-Calvet E
    Parasit Vectors; 2017 Apr; 10(1):210. PubMed ID: 28449693
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Lassa serology in natural populations of rodents and horizontal transmission.
    Fichet-Calvet E; Becker-Ziaja B; Koivogui L; Günther S
    Vector Borne Zoonotic Dis; 2014 Sep; 14(9):665-74. PubMed ID: 25229705
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers.
    Rieger T; Merkler D; Günther S
    PLoS One; 2013; 8(8):e72290. PubMed ID: 23991083
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Pathogenesis of Lassa fever.
    Yun NE; Walker DH
    Viruses; 2012 Oct; 4(10):2031-48. PubMed ID: 23202452
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa.
    Coulibaly-N'Golo D; Allali B; Kouassi SK; Fichet-Calvet E; Becker-Ziaja B; Rieger T; Olschläger S; Dosso H; Denys C; Ter Meulen J; Akoua-Koffi C; Günther S
    PLoS One; 2011; 6(6):e20893. PubMed ID: 21695269
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
    Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
    Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 118. An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.
    Lelke M; Brunotte L; Busch C; Günther S
    J Virol; 2010 Feb; 84(4):1934-44. PubMed ID: 20007273
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro.
    Günther S; Asper M; Röser C; Luna LK; Drosten C; Becker-Ziaja B; Borowski P; Chen HM; Hosmane RS
    Antiviral Res; 2004 Sep; 63(3):209-15. PubMed ID: 15451189
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.
    Asper M; Sternsdorf T; Hass M; Drosten C; Rhode A; Schmitz H; Günther S
    J Virol; 2004 Mar; 78(6):3162-9. PubMed ID: 14990737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.